Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry, v3.6.3, is added to the study record history. The previous revision, v3.6.2, is removed from the history, updating the version trail for this record.
    Difference
    0.1%
    Check dated 2026-07-03T15:08:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision history now shows a newer release (v3.6.2) and replaces the older v3.6.0 entry, reflecting a maintenance update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-06-26T20:27:11.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record history now shows new labels 'Last verified' and 'Last known status was' and adds a new revision entry 'Revision: v3.6.0'; the older labels 'Verified' and 'Last known status was:' plus the older 'Revision: v3.5.5' are removed from this view.
    Difference
    3%
    Check dated 2026-06-12T23:00:37.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The Record History now lists Revision: v3.5.5 as the latest entry in the Study Record Versions. The previous Revision: v3.5.4 entry has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:05.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision label now reads v3.5.4, replacing the previous v3.5.3; this indicates a minor metadata update without altering the study content or data.
    Difference
    0.2%
    Check dated 2026-05-15T15:23:53.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page’s displayed software/version label changes from Revision v3.5.2 to v3.5.3, reflecting a site update rather than any modification to the clinical trial’s study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:40:41.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.